Our Cluster is delighted to announce that Prof. Dr. Kaan Boztug, a renowned immunologist and pediatrician from Vienna, has joined our growing scientific community in Bonn. Kaan Boztug, previously Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and Scientific Director of the St. Anna Children’s Cancer Research Institute (CCRI), brings his expertise in rare immune disorders to Bonn, further strengthening the interdisciplinary research network. Alongside his role in the ImmunoSensation excellence cluster, Kaan Boztug will be the Director of the newly established Clinic for Pediatric Immunology and Rheumatology at the University Hospital Bonn.
Research Focus: Rare Immune Disorders and Precision Medicine
The research of Kaan Boztug focuses on uncovering the genetic and molecular foundations of rare immune system disorders. His work, supported by an ERC Starting Grant (2012–2018) and an ERC Consolidator Grant (2019–2025), has led to the discovery of more than 20 previously unknown inborn errors of immunity. These findings have been pivotal in elucidating the roles of specific genes and proteins in immune system dysfunction, with a focus on immunodeficiencies characterised by susceptibility to infections, as well as immune dysregulation that influence autoimmunity and autoinflammation.
By using advanced methodologies, such as whole-exome and whole-genome sequencing, functional genomics, and patient-derived disease models, the research group of Kaan Boztug translates scientific discoveries into innovative therapeutic approaches. His work may identify targeted treatments tailored to the unique genetic makeup of each patient.
Bonn - A Global Hub for Immunology
Kaan Boztug chose to join the Cluster of Excellence ImmunoSensation2 in Bonn to contribute to and benefit from its exceptional research environment.
"ImmunoSensation is a forward-thinking immunology research cluster. Its emphasis on interdisciplinary collaboration, translational research, and clinical integration aligns perfectly with my vision of connecting science with patient care," Kaan Boztug shared.
The research landscape in Bonn, enriched by institutions like the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), and the University Hospital Bonn, offers an ideal platform for translating immunological discoveries into medical advancements.
Looking Ahead: Perspectives and Goals
At ImmunoSensation2, Kaan Boztug is eager to broaden his research scope and foster collaborative projects aimed at understanding immune dysfunction and developing innovative therapies.
"Bonn provides a unique opportunity to work with world-class scientists across multiple disciplines. I look forward to contributing to the Cluster’s mission of advancing our understanding of the immune system and improving human health," he added.
We warmly welcome Kaan Boztug to Bonn and are excited about the innovative contributions his research will bring to our community and the field of immunology.
